Assessment of the hypothalamic-pituitary-adrenal axis function after corticosteroid therapy for MS relapses
- 29 January 2009
- journal article
- research article
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 81 (6) , 524-528
- https://doi.org/10.1111/j.1600-0404.1990.tb01013.x
Abstract
Doses of corticosteroids usually given for relapses of MS are able to suppress the hypothalamic-pituitary-adrenal (HPA) axis. We evaluated HPA axis function using rapid ACTH stimulation and rapid overnight metyrapone tests, just after cessation of regular oral prednisone therapy for relapses in 14 MS patients. Nine additional patients treated with i.v. boluses of methylprednisolone before beginning conventional oral therapy were also evaluated. Sixteen patients had normal response to both tests and 6 patients had only a discordant response to one test. These data indicate that most patients had normal HPA axis function, which make corticosteroid replacement unnecessary after cessation of therapy for relapses.Keywords
This publication has 14 references indexed in Scilit:
- Double-Blind Randomized Trial of ACTH versus Dexamethasone versus Methylprednisolone in Multiple Sclerosis BoutsEuropean Neurology, 1989
- Assessment of hypothalamic-pituitary-adrenal (HPA) axis dysfunction: comparison of ACTH stimulation, insulin-hypoglycemia and metyraponeJournal of Endocrinological Investigation, 1988
- Treatment for an Acute ExacerbationPublished by Springer Nature ,1988
- Steroid Therapy in Multiple SclerosisArchives of Neurology, 1987
- Drug Treatment of Multiple SclerosisSeminars in Neurology, 1987
- Dexamethasone suppression test abnormalities in multiple sclerosisNeurology, 1987
- A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects.Journal of Neurology, Neurosurgery & Psychiatry, 1987
- The Current Management of Multiple SclerosisAnnals of the New York Academy of Sciences, 1984
- Rating neurologic impairment in multiple sclerosisNeurology, 1983
- Withdrawal from Glucocorticoid TherapyNew England Journal of Medicine, 1976